vinblastina kabi polvo liofilizado para solución inyectable
bioxel - polvo liofilizado para solución inyectable - vinblastina 10 mg inyectable
vinblastina sulfato farmaco uruguayo polvo liofilizado para solución inyectable
farmaco uruguayo - polvo liofilizado para solución inyectable - vinblastina 10 mg inyectable
vinblastina liofilizado para solución inyectable 10 mg con solvente
munnich pharma medical ltda. - sin formulas
vinblastina sulfato solución inyectable 10 mg/10 ml
laboratorios lafi ltda. - sin formulas
vinblastina sulfato solución inyectable 10 mg/10 ml
laboratorio biotoscana farma ltda. - sin formulas
vinblastina sulfato solución inyectable 10 mg/10 ml
munnich pharma medical ltda. - sin formulas
adcetris
takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agentes antineoplásicos - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.
vinblastina 10 mg polvo para solucion inyectable
palmagyar s.a. - polvo para solucion inyectable
vinblastina 10 mg polvo para solucion inyectable
drogueria aventis pharma s.a. - polvo para solucion inyectable
vinblastina sulfato 1 mg